Skip to main content
. 2017 Oct 23;2017:8196434. doi: 10.1155/2017/8196434

Table 2.

Response to pemetrexed in the 2 cohorts.

Variable Exon 19 (n = 33) Exon 21 (n = 22)
CR
PR 11 5
SD 11 5
PD 6 5
Not evaluable 5 7